Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.15B | 44.65B | 46.38B | 37.62B | 33.03B | 31.12B |
Gross Profit | 2.89B | 2.54B | 4.38B | 1.93B | 1.62B | 244.00M |
EBITDA | 1.81B | 2.06B | 3.44B | 2.01B | 1.27B | 103.00M |
Net Income | 919.00M | 1.02B | 2.26B | 737.00M | 143.00M | -971.00M |
Balance Sheet | ||||||
Total Assets | 43.67B | 42.49B | 43.82B | 40.20B | 36.81B | 34.04B |
Cash, Cash Equivalents and Short-Term Investments | 12.94B | 4.70B | 14.80B | 9.31B | 16.28B | 7.45B |
Total Debt | 5.56B | 5.68B | 8.96B | 9.41B | 9.71B | 9.98B |
Total Liabilities | 33.17B | 31.63B | 34.08B | 32.78B | 30.02B | 27.27B |
Stockholders Equity | 10.50B | 10.86B | 9.74B | 7.43B | 6.79B | 6.78B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -6.58B | 5.96B | -7.88B | 9.28B | -5.61B |
Operating Cash Flow | 0.00 | -5.38B | 6.75B | -6.38B | 10.78B | -4.10B |
Investing Cash Flow | 0.00 | -1.20B | -824.00M | -249.00M | -1.68B | -1.53B |
Financing Cash Flow | 0.00 | -3.44B | -528.00M | -359.00M | -278.00M | 1.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥210.17B | 8.01 | 28.11% | 1.04% | 17.94% | 31.45% | |
78 Outperform | ¥9.55B | 7.93 | 2.66% | 7.08% | 165.25% | ||
74 Outperform | ¥259.50B | 6.68 | 24.36% | 0.78% | 4.38% | 55.40% | |
71 Outperform | ¥254.21B | 13.40 | 8.49% | 3.03% | 6.33% | 12.89% | |
68 Neutral | ¥9.51B | 9.34 | 0.71% | -3.74% | -55.02% | ||
67 Neutral | ¥3.26B | 86.62 | 1.22% | -1.11% | 2.09% | ||
62 Neutral | ¥9.78B | 18.23 | 2.32% | 15.54% | -47.78% |